MedTrace Logo

Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne

NCT01220102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3113

Last updated 2016-02-17

No results posted yet for this study

Summary

The purpose of this observational study is to assess the efficacy of Epiduo and patient adherence under daily clinical practice conditions in adults and adolescents (12 to 20 years) with moderate inflammatory acne using this drug first time in topical monotherapy.

Conditions

Interventions

DRUG

0.1% adapalene/ 2.5% benzoyl peroxide

topical application, once per day

Sponsors & Collaborators

  • Galderma Laboratorium GmbH

    lead INDUSTRY

Principal Investigators

  • Harald PM Gollnick, Prof. Dr. · Universitätsklinikum Magdeburg A.ö.R Klinik für Dermatologie und Venerologie

Eligibility

Min Age
12 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220102 on ClinicalTrials.gov